ECTTA, ESC & ERS Specialty Update Symposium

Molecular diagnostics in thoracic transplantation

SUNDAY 24 SEPTEMBER | 09:00-12.50


SESSION 1 - ECTTA & ERS joint session - To provide insights in key features of lung transplantation
CHAIRS : Arne Neyrinck, Leuven, Belgium
               Robin Vos, Leuven, Belgium

09:00                      How to personalise CLAD management
                              Robin Vos, Leuven, Belgium

09:20                      Can LAS survive in Europe
                              Jens Gottlieb, Hannover, Germany

09:40                      Should we move from ventilation to awake ECMO?
                              Alexis Slama, Vienna, Austria

10:00                      Is EVLP a tool for immunoregulation?
                              James Fildes, Manchester, United Kingdom

10:20                      How extended is my donor?
                              Christian Benden, Zurich, Switzerland

10.40–11.00             Break

SESSION 2 - ECTTA & ESC joint session - Advanced heart failure - when drugs alone are not enough: a case-based approach

CHAIRS : Sharon Hunt, Palo Alto, United States
               Luciano Potena, Bologna, Italy

11.00                      The patient sliding on inotropes: is my patient too frail to recover after VAD or transplant?
                              Peter Macdonald, Darlinghurst, Australia

11.20                      Right ventricular failure: LVAD, temporary RVAD or BiVAD?
                              Arjang Ruhparwar, Heidelberg, Germany

11.40                      When to refer a patient for heart transplant or LVAD: a stepwise approach
                              Kristjan Karason, Gothenburg, Sweden

12.00                      Palliation and end of life care in end-stage heart failure
                              James Beattie, London, United Kingdom





OBJECTIVES | To provide updates on the etiologies, mechanisms, treatment strategies and diagnostic tools of early and late dysfunction of the transplanted heart and lungs. The lectures will focus on the main strategies and mechanisms leading to graft dysfunction starting from donor and organ management, to prevention of long-term chronic immunological injury leading to graft impairment.

TARGET AUDIENCE |Cardiologist, Pneumologists, Cardio-thoracic surgeons, Anestesiologists, Transplant coordinators.


The European Cardio Thoracic Transplant Association has been endorsed to promote initiatives aimed at improving the educational and scientific opportunities ESOT can offer to professionals involved in heart and lung transplantation

GOALS |Our ambition is to become a gathering home to foster scientific growth, exchange programs, collaborative projects and funding opportunities dedicated to European heart and lung transplantation programs.

AIM |Improve quality of care for patients with end-stage heart or lung disease and for thoracic organ transplant recipients. Advance education and stimulate networking amongst thoracic transplant professionals.